Cetera Investment Advisers Geron Corp Transaction History
Cetera Investment Advisers
- $55.9 Billion
- Q2 2025
A detailed history of Cetera Investment Advisers transactions in Geron Corp stock. As of the latest transaction made, Cetera Investment Advisers holds 23,830 shares of GERN stock, worth $25,736. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,830
Previous 24,699
3.52%
Holding current value
$25,736
Previous $39,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GERN
# of Institutions
286Shares Held
511MCall Options Held
884KPut Options Held
564K-
Ra Capital Management, L.P. Boston, MA60.4MShares$65.2 Million1.86% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$50.3 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT43MShares$46.4 Million2.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.4MShares$37.2 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$29.4 Million8.13% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $408M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...